Navigation Links
FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations,,FDA Regulations

Is FDA Equipped to Meet Pace of Innovations and a Health Conscious Public?

WASHINGTON, April 30, 2007 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) must adapt to the most significant changes in the history of healthcare, Commissioner Andrew von Eschenbach told attendees at the Food and Drug Law Institute's 50th Annual Conference April 12 in Bethesda, Md.

FDA must find creative "bridging" ways to use its limited financial and personnel resources to deal with the challenges led by scientific breakthroughs increasing health benefits but also risks in foods, drugs and devices, von Eschenbach told the industry representatives, compliance officers, health policymakers, physicians, regulators and attorneys attending the FDLI meeting.

Keynote speaker Sen. Ron Wyden (D-Ore.), sponsor of The Healthy Americans Act -- omnibus legislation to reform the healthcare system in the United States -- said that it was vitally important that Democrats and Republicans work together to enable FDA to improve the drug delivery process. The Healthy Americans Act seeks to provide universal, affordable, quality health coverage to all Americans.

The landmark FDLI conference focused on the impact of scintillating scientific discoveries that are driving technological innovation in health care and the impact of those changes on FDA and pharmaceutical and device manufacturers, as well as the food industry. Industry leaders, including representatives from Siemens and Amgen, provided a glimpse into the future of personalized medicine. Expert panels discussed how these innovations would affect reimbursement, claims, food marketing and safety, clinical research, drug evaluation, radiological health and veterinary medicine. Representatives from all major FDA centers provided inside information on new agency initiatives in these areas.

This 50th FDLI annual meeting also marked a reinvigorated FDLI focus
'"/>




Page: 1 2

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
4. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
5. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
6. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
7. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
8. MaxCyte and Medinet to Present at the 13th Annual Meeting of the International Society for Cellular Therapy (ISCT) in Sydney, Australia
9. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
10. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
11. Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting

Post Your Comments:
(Date:12/2/2009)...c. 2 Novartis announced today that...on Tasigna® (nilotinib) 200 mg capsules in a ...strength of the company,s hematology portfolio in ...a, at the 51st American Society of Hematology (ASH...pany,s current therapies and investigational agent...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Medical Oxygen Systems - Global Market Op...0164334/Medical-Oxygen-Systems---Global-Market-Opp...stems market for home healthcare setting is reckon...wth expectations stem from demographic factors suc...
(Date:12/1/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Molecular Diagnostics - A World Market Rev...olecular-Diagnostics---A-World-Market-Review.html ...n by several growth factors that include the need ... combine optimized sample preparation, analysis, a...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 2Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 3Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 4Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 5Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 6Reportlinker Adds Medical Oxygen Systems - Global Market Opportunities 7Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 1OneDotOneLife org Saving the Lives of More Than 2 Million Children 5048 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 1Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 2Pres Clinton Announces Commitment From Inter American Development Bank Global Network for Neglected Tropical Diseases and Pan American Health Organ 5046 3Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 1Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 2Regence to Cover Administration Costs of H1N1 Vaccine for Fully Insured Groups Individuals This Flu Season 5044 3
...J., Oct. 29 Sanofi-aventis,announced today that t...d,Apidra(R) (insulin glulisine [rDNA origin] injec...ears and older) with diabetes mellitus., The appr...FDA review of,a 26-week, phase III, open-label, ac... insulin lispro, in 572 children and adolescents (...
..., Oct. 29 CuraGen Corporation,(Nasdaq: CRGN ), a...on,oncology, announced today that Company executiv...t 11:00 a.m. ET on Monday, November 3, 2008,follow...sults and to review,preliminary data from CuraGen,...for the treatment of advanced melanoma., Data fro...
Other Medicine Technology:FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 2FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 3FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 4FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes 5CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008 2
(Date:12/2/2009)..., A team of Kendall Hunt ...er of the Year Award at the recent National Associ...e in St. Louis, November 5-7, 2009. , ...-- A team of Kendall Hunt authors earned the 2009 ...the recent National Association for Gifted Childre...
(Date:12/2/2009)..., , Ad in Today,s Washington Post ...ewswire-USNewswire/ -- If the Catholic bishops ...tative measures we take for granted may be under t...ght to bear on the debate over healthcare reform h...Washington Post warns of the likely impact if tha...
(Date:12/2/2009)... Insect repellents suspected in birth defect that ..., WEDNESDAY, Dec. 2 (HealthDay News) -- Male babie...rst three months of pregnancy appear to be at incr...researchers report. , This birth defect, which ...ves premature shortening of the urethra, the tube ...
(Date:12/2/2009)..., , Fruit flies may seem like unlikely heroes in ...ggests that these insects already used to study d...entists are reporting that fruit flies can be used... studying the effects of cocaine and other drugs o...n ACS Chemical Neuroscience , a new monthly journ...
(Date:12/2/2009)..., MyCareTeam, Inc., a lea...gement software, has released the newest version o...udes hypertension, congestive heart failure and we...isting diabetes monitoring features. , ...9 -- MyCareTeam, Inc., a leading vendor of Interne...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2
...our out of five hospitalized children receive medi...r adults//. The authors fear that treating childre...omes. "We measured the magnitude of off-labe...hiladelphia. "Given the nature of the available da...
...in Nigeria has been a success, but continued commi...icate the virus from northern states, say official...ive was launched in May 2006 by the National Progr...egions still affected by the virus. People i...
...ly diagnosis of lung cancer. They hope the analysi.../ lining the airways leading to the lungs can be u...s more effective. Lung cancer is the most dead...d and nearly 29,000 deaths. Part of the reas...
...sults of a study showing clearly that soft drinks ...gher body weight, a decrease in calcium and other ... The report also noted that studies funded b...le analyzed 88 previously published studies obtain...
...e accurate amount of fat in a human body, accordin... as the standard for measuring the amount of fat i...'s body weight divided by the square of their heig... at a greater risk of heart disease, diabetes and ...
...on educated in India, was Monday conferred with th... Ruit has conducted over 70,000 surgeries fo...indness in the subcontinent. "It is an apt a...d surgeon at the award ceremony here. Ruit h...
Other Medicine News:Health News:Prescribing Off Label Drugs for Children may Be Hazardous 2Health News:Prescribing Off Label Drugs for Children may Be Hazardous 3Health News:Nigerian Programme Increases Polio Immunisation 2Health News:Gene Cell Test may Aid Early Lung Cancer Diagnosis 2Health News:Yale Researchers Weigh the Science on Soft Drinks and Health 2
Shandon Pathcentre Tissue Processor
Shandon Excelsior Tissue Processor
Shandon Grosslab Junior Grossing Workstation
Shandon Hyperclean 2 Fume Handling Station
Medicine Products: